Accessibility Menu
 
Cannara Biotech logo

Cannara Biotech

(OTC) LOVFF

Current Price$1.32
Market Cap$130.39M
Since IPO (2019)-26%
5 Year+3%
1 Year+43%
1 Month+1%

Cannara Biotech Financials at a Glance

Market Cap

$130.39M

Revenue (TTM)

$112.67M

Net Income (TTM)

$11.81M

EPS (TTM)

$0.09

P/E Ratio

14.32

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$1.32

Volume

100

Open

$1.32

Previous Close

$1.32

Daily Range

$1.32 - $1.32

52-Week Range

$0.77 - $1.47

LOVFF News

No articles available.

LOVFF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannara Biotech

Industry

Personal Products

Employees

452

CEO

Zohar Krivorot

Headquarters

Saint-Laurent, QC H4N 3M9, CA

LOVFF Financials

Key Financial Metrics (TTM)

Gross Margin

39%

Operating Margin

14%

Net Income Margin

10%

Return on Equity

12%

Return on Capital

11%

Return on Assets

7%

Earnings Yield

6.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$130.39M

Shares Outstanding

98.78M

Volume

100

Short Interest

0.00%

Avg. Volume

5.51K

Financials (TTM)

Gross Profit

$47.22M

Operating Income

$22.20M

EBITDA

$28.18M

Operating Cash Flow

$20.01M

Capital Expenditure

$6.36M

Free Cash Flow

$13.65M

Cash & ST Invst.

$14.36M

Total Debt

$41.58M

Cannara Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$30.11M

+20.1%

Gross Profit

$11.21M

+10.1%

Gross Margin

37.23%

N/A

Market Cap

$130.39M

N/A

Market Cap/Employee

$282.85K

N/A

Employees

461

N/A

Net Income

$1.04M

-54.9%

EBITDA

$4.23M

-25.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$18.29M

+52.8%

Accounts Receivable

$15.22M

+17.7%

Inventory

$51.97M

+24.5%

Long Term Debt

$25.67M

-22.2%

Short Term Debt

$9.14M

-42.8%

Return on Assets

6.79%

N/A

Return on Invested Capital

11.14%

N/A

Free Cash Flow

$3.34M

-27.6%

Operating Cash Flow

$7.96M

+36.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOYFBioSyent Inc.
$11.24+0.54%
CBWTFAuxly Cannabis Group Inc.
$0.09-2.53%
SHIEFShield Therapeutics plc
$0.14+0.00%
HLTRFHLS Therapeutics Inc.
$3.36+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About LOVFF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.